Back to Dashboard
LLY · Healthcare

ELI LILLY & CO

USA Healthcare Filing: 2026-03-31
Smart-money confidence · 1 of 3 sources firing
Moderate — mixed signals

No standout activity across the feeds we track.

Hedge funds
64
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. ELI LILLY & CO is not currently in our model portfolio, but 11 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$1.05T
Industry
Drug Manufacturers - General
Exchange
NYSE
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the…
11
Investors
2
New positions
5
Increasing
3
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Soros Fund Management (Soros)
Trust weight: 1.5×
New position
% of portfolio
0.4%
Position change
NEW
0.4% of Soros Fund Management's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
New position
% of portfolio
0.3%
Position change
NEW
0.3% of Tudor Investment's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Increased +602%
% of portfolio
0.3%
Position change
+602%
0.3% of Bridgewater Associates's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +12%
% of portfolio
0.3%
Position change
+12%
0.3% of AQR Capital Management's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +12%
% of portfolio
0.3%
Position change
+12%
0.3% of Millennium Management's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +852%
% of portfolio
0.1%
Position change
+852%
0.1% of Point72's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Increased +41%
% of portfolio
0.0%
Position change
+41%
0.0% of Gotham Asset Mgmt's portfolio
Elliott Investment Mgmt
Trust weight: 1.3×
Decreased −3%
% of portfolio
0.7%
Position change
−3%
0.7% of Elliott Investment Mgmt's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −39%
% of portfolio
0.5%
Position change
−39%
0.5% of Citadel Advisors's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −14%
% of portfolio
0.4%
Position change
−14%
0.4% of D.E. Shaw & Co's portfolio
Polen Capital Management
Trust weight: 1.3×
Unchanged
% of portfolio
0.1%
Position change
—
0.1% of Polen Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ELI LILLY & CO
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ELI LILLY & CO or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API